⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15604781 | 0.72 | TP53 (0.38) | — | |
| SCHEMBL18789280 | 0.72 | NPSR1 (0.35) | — | |
| SCHEMBL18849596 | 0.72 | NPSR1 (0.35) | — | |
| SCHEMBL1469083 | 0.71 | — | — | |
| SCHEMBL18789232 | 0.71 | NPSR1 (0.34) | — | |
| SCHEMBL26155014 | 0.69 | LMNA (0.30) | — | |
| SCHEMBL23430890 | 0.69 | ANPEP (0.31) | — | |
| SCHEMBL584593 | 0.69 | ANPEP (0.31) | — | |
| SCHEMBL25841430 | 0.68 | CYP3A4 (0.42) | — | |
| SCHEMBL12919609 | 0.68 | NPSR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234954-A1 | COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF | TYK MEDICINES, INC. (CN) | 2023-07-27 | — | — | US | disclosed |
| US-20230234954-A1 | COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF | TYK MEDICINES, INC. (CN) | 2023-07-27 | — | — | US | disclosed |